Flashcards · Module 16
🫁 Lungs & Dangerous Infections (Pulmonology)
4 of 4 cards published · read by the site’s author on 17 November 2026
Asthma-COPD Overlap (ACO) & The Inhaler Trap
Needs clinical review
What is ACO?
A patient aged ≥40 who has persistent airflow obstruction (post-bronchodilator FEV1/FVC <0.70) combined with features of both conditions:
Asthma features: History of childhood asthma, allergies/atopy, blood eosinophils ≥300 cells/μL, or bronchodilator reversibility (>12% and >200 mL).
COPD features: Heavy smoking history (>10 pack-years), emphysema on CT, chronic productive cough.
Treatment: Always include an Inhaled Corticosteroid (ICS) alongside long-acting bronchodilators (LABA/LAMA) — never give a LABA alone in asthma!
The Inhaler Technique Failure (The Real-World Trap):
Matching the inhaler device to patient-specific capabilities is critical; inadequate inspiratory flow and device mismatch are strongly associated with treatment failure and exacerbations.
| Inhaler Type | How It Works | Why Frail Elders Fail It | The Solution |
|---|---|---|---|
| Dry Powder Inhaler (DPI) (e.g. Diskus, Turbuhaler) | Breath-actuated; the patient's own inspiration disperses the powder | Needs enough inspiratory flow (thresholds of about 30–60 L/min, depending on the device); frail patients may not reach it | |
| Metered-Dose Inhaler (MDI) | Pressurized aerosol canister | Requires fine coordination: press canister while taking a slow deep breath (arthritis + dementia ruin this) | Attach a Valved Holding Chamber (Spacer) with mask! |
Sources checked (3) · 15 November 2026
- Asthma and chronic obstructive disease overlap (ACO), a systematic review of prevalence and co-morbidity factors based on diagnostic criteria (2026)
- An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics (2026)
- Personalizing Inhaled Therapy in COPD and Asthma: Integrating Drug, Device, and Patient Factors (2026)
Note: In the source's table, a pMDI with a valved holding chamber delivered 52% of the dose to the lungs, against 21% for a pMDI alone and 3% for a standard jet nebulizer. (Personalizing Inhaled Therapy in COPD and Asthma: Integrating Drug, Device, and Patient Factors (2026))
Aspiration Pneumonia: Oral hygiene as prevention
Needs clinical review
The Pathophysiology:
Impaired swallowing (dysphagia from stroke, dementia, Parkinson's)
Loss of cough reflex (sedatives, opioids, anticholinergics)
Aspiration of oropharyngeal secretions into dependent lung segments (right lower lobe, superior segment of lower lobes)
The Microbiology Shift:
Healthy young outpatients aspirate mouth streptococci. But hospitalized or institutionalized frail older adults develop rapid mouth colonization by Gram-negative enteric rods (Klebsiella, E. coli, Pseudomonas) and Staphylococcus aureus, in addition to oral anaerobes.
The 4-Step Aspiration Prevention Bundle:
🪑 Upright Seating: feed sitting upright, not lying down: upright sitting is linked to less swallowing difficulty than lying.
🪥 Aggressive Oral Hygiene: Standardized oral hygiene protocols and tooth brushing are linked to substantial falls in hospital-acquired pneumonia (up to 85% in some units). Clean mouths mean cleaner aspirate.
🥣 Texture Modification (IDDSI): Nectar-thick liquids and pureed soft foods prevent airway flooding.
💊 Deprescribing: Discontinue sedatives, benzodiazepines, and anticholinergics that numb swallowing reflexes.
Sources checked (6) · 15 November 2026
- A Narrative Review of Oral Hygiene and Pulmonary Health Amid Dysphagia: Implications for Feeding Route, Nutrition, and Quality of Life (2026)
- Oral Hygiene Interventions and Pneumonia Prevention in Critical Care: An Integrative Review of Evidence and Practice (2026)
- Host, Pathogen, and Pulmonary Anatomy in Pneumonia: An Integrated Imaging and Clinical Perspective (2026)
- Oral Frailty and Meal Positioning Associated With Aspiration Pneumonia in Long-Term Care Residents at High Risk of Malnutrition (2026)
- The Value of Prevention: Clinical Nurse Specialist-Led Strategies to Reduce Hospital-Acquired Adverse Events (2026)
- Do's and Don'ts in Mealtime Management for People with Oropharyngeal Dysphagia: A Modified Delphi Consensus Study from the Italian Society of Deglutology (2026)
Note: For ventilator-associated pneumonia, tooth brushing with 0.12% chlorhexidine ranked highest, followed by 0.12% chlorhexidine alone and brushing alone. (A Narrative Review of Oral Hygiene and Pulmonary Health Amid Dysphagia: Implications for Feeding Route, Nutrition, and Quality of Life (2026))
Bacterial Meningitis in Elders: Why Ampicillin is MANDATORY!
Needs clinical review
The Clinical Trap:
A 74-year-old presents with lethargy, mild hypothermia (35.8°C), and acute confusion. There is NO stiff neck (no nuchal rigidity) and no fever! CSF shows cloudy fluid with 1,200 neutrophils.
Why Classical Signs Are Missing:
In people aged 80 and over, the classic triad (fever, neck stiffness, altered consciousness) was present in only 43%, and atypical bacteria such as Listeria were more common.
The Bug You Cannot Miss: Listeria monocytogenes
Listeria is a foodborne Gram-positive bacillus found in unpasteurized cheeses, cold deli meats, and pre-packaged foods.
Older adults are an at-risk group for invasive Listeria infection.
The Empiric Antibiotic Regimen:
Usual empirical backbone: a third-generation cephalosporin (ceftriaxone or cefotaxime).
🚨 THE FATAL GAP: Ceftriaxone and Vancomycin have ZERO activity against Listeria!
Older adults: add AMPICILLIN to cover Listeria, which cephalosporins do not treat.
Sources checked (3) · 15 November 2026
Shingles (Herpes Zoster) & The Agony of Post-Herpetic Neuralgia
Needs clinical review
What is Shingles?
Reactivation of latent Varicella Zoster Virus (VZV) sleeping in the dorsal root ganglion, erupting as a painful, unilateral, dermatomal vesicular rash.
The Real Enemy: Post-Herpetic Neuralgia (PHN)
Defined as severe, burning, stabbing neuropathic pain persisting >90 days after the shingles rash has fully healed.
About 10–20% of people with shingles develop PHN, with persistent pain, poor sleep and depression.
Prevention — The Vaccine Gold Standard:
Shingrix (RZV): A 2-dose recombinant adjuvanted non-live vaccine for all adults aged ≥50.
In the ZOE-50 and ZOE-70 trials, >90% efficacy against shingles (it replaced the older live vaccine, Zostavax).
Treatment Protocol:
Acute Rash (<72 hours from onset): Start Valacyclovir (1000 mg PO TID for 7 days) to speed rash healing and reduce PHN risk.
Post-Herpetic Neuralgia Pain:
🥇 First-line topical: Lidocaine 5% patch (minimal systemic side effects).
🥈 First-line systemic: Gabapentin or Pregabalin (tier 1A), or Duloxetine (tier 1B).
⚠️ Use with caution: Amitriptyline / TCAs: anticholinergic, causing confusion, urinary retention and tachycardia.
Sources checked (3) · 15 November 2026
- Current advances in the epidemiology, risk factors, prevention, management, and long-term outcomes of herpes zoster and post-herpetic neuralgia (2026)
- Postherpetic Neuralgia: Mechanisms, Risk Factors, and Stratified Management-A Narrative Review (2026)
- Anticholinergic burden in community-dwelling older adults: prevalence, associated factors, and agreement between measurement scales (2026)
Note: Inadequately managed chronic pain, such as PHN, can lead to depression, anxiety and, in severe cases, suicide. (Postherpetic Neuralgia: Mechanisms, Risk Factors, and Stratified Management-A Narrative Review (2026))
Note: The FDA-approved dosage of valacyclovir for herpes zoster is 1 gram orally 3 times daily for 7 days. (VALACYCLOVIR HYDROCHLORIDE tablet, film coated)